Hilltop Biosciences Inc. — Form D/A
Hilltop Biosciences Inc. of Norwood, MA, a company, filed a Form D amendment with the SEC on 2025-03-31. The offering totals $5.5M, of which $5.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-31
- Form: D/A
- Accession: 0001782084-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.5M
- Amount sold: $5.3M
- Remaining: $196K
- Investors: 73
- Date of first sale: 2024-11-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-531956
Issuer
- Name: Hilltop Biosciences Inc.
- CIK: 0001782084
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 320 Norwood Park, S, Norwood, MA, 02062
- Phone: 617-237-0636
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Denise Bevers | Director | Norwood, MA |
| Amanda Drobnis | Director | Norwood, MA |
| Jessica McLear | Director | Norwood, MA |
| Alan Watson | Director | Norwood, MA |
| Mark Williams | Director | SAN JUAN, PR |
| Amanda Drobnis | Executive Officer | Norwood, MA |
| Mark Williams | Executive Officer | SAN JUAN, PR |
| Denise Beavers | Director | Mansfield, MA |
| Jill Wittels | Director | Norton, MA |
Other filings by this issuer (8)
More